Skip to main content
. 2018 Apr 29;9(4):250–255. doi: 10.1136/flgastro-2017-100936

Figure 5.

Figure 5

An overview of concerns regarding the use of faecal microbiota transplantation (FMT) in patients with inflammatory bowel disease (IBD) where 1 is ‘least concerning’ and 6 is ‘most concerning’.